ARTV today
$4.07+$0.01 (+0.25%)close Nov 11, 2026Trend
DailyDowntrend (starting)
4 hourLeaning Bullish
1 hourBearish
15 minBearish
5 minStrong Bullish
Daily trend turns up above $14.53
Key levels
Resistance$5.08
Resistance$4.45
Support$4.00
Support$3.62
Latest news & SEC filings
LegalLaw firm opens investigation into Artiva Biotherapeutics
NewsArtiva Biotherapeutics flags $10M-$15M AlloNK wind-down charges, $17M-$20M severance bill
All ARTV news →About Artiva Biotherapeutics
Artiva Biotherapeutics is a clinical-stage biotechnology company that creates cell therapies using natural killer cells to treat autoimmune conditions and cancer. Its main candidate, AlloNK, is a frozen, off-the-shelf therapy made from donor cells and given with monoclonal antibodies to deplete B cells. The company also develops CAR-NK candidates AB-201 and AB-205 and runs a manufacturing site in San Diego, California.
Based on the company's 10-K filed Mar 10, 2026.
Nasdaq · Healthcare
Artiva Biotherapeutics, Inc. (ARTV)
What Is the Price Target for ARTV?
SEPT Low Target
$4.00
SEPT Mid Target
$40.00
SEPT High Target
$41.00
Analyst Consensus
$40.00
Is ARTV a Buy or Sell Right Now?
Thesis
- •Revenue growing -99.2% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ARTV.
Start Free Trial →Is ARTV Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$35.70
12
Moat Score
NONE
1/9
Piotroski Score
-2.0
Altman Z-Score
What Is Smart Money Doing with ARTV?
Insider Signal
SELLING
3 buys / 12 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Horan Christopher | officer | Sale | 10,423 | $44K | Nov 2, 2026 |
| Bush Jennifer | officer | Sale | 8,439 | $35K | Nov 2, 2026 |
| Banerjee Subhashis | officer | Sale | 1,110 | $5K | Nov 2, 2026 |
| Aslan Fred | director officer | Sale | 62,178 | $260K | Nov 2, 2026 |
| Aslan Fred | director officer | Sale | 23,463 | $169K | Oct 6, 2026 |
| Horan Christopher | officer | Sale | 10,340 | $71K | Oct 5, 2026 |
| Bush Jennifer | officer | Sale | 8,370 | $57K | Oct 5, 2026 |
| Banerjee Subhashis | officer | Sale | 1,099 | $8K | Oct 5, 2026 |
| Aslan Fred | director officer | Sale | 61,696 | $422K | Oct 5, 2026 |
| Miralles Gines Diego | officer | Buy | 45,000 | - | Sep 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ARTV Growth Story
Revenue YoY
-99.3%
3yr Revenue CAGR
N/A%
EPS Growth YoY
40.96%
FCF Growth YoY
-42.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for ARTV
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ARTV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:15 | $4.08 | 1,010 | $$4K | SELL |
| 20:58:12 | $4.08 | 1,166 | $$5K | SELL |
| 20:56:14 | $4.08 | 1,200 | $$5K | MIDPOINT |
| 20:47:17 | $4.10 | 2,500 | $$10K | BUY |
| 20:47:17 | $4.10 | 1,400 | $$6K | BUY |
5 dark pool trades shown · $$30K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ARTV
PREVIEWSEPT Investing provides real-time options flow tracking for ARTV, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Feb 19 | 100 | $$80 | 2 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$240 | 6 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$80 | 2 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$80 | 2 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$560 | 14 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Artiva Biotherapeutics, Inc. (ARTV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ARTV — frequently asked questions
What is ARTV stock price today?
Artiva Biotherapeutics, Inc. (ARTV) is at $4.07, up 0.25% (+$0.01) at the Nov 11, 2026 close.
Why is ARTV stock moving today?
Latest ARTV news — Nov 10, 2026: Law firm opens investigation into Artiva Biotherapeutics · Nov 9, 2026: Artiva Biotherapeutics flags $10M-$15M AlloNK wind-down charges, $17M-$20M severance bill
Why did ARTV stock move on Oct 27, 2026?
Artiva Biotherapeutics announced it is halting development of its lead candidate AlloNK and initiating a strategic review, which will result in cutting approximately 94% of its staff. The company also canceled a planned data presentation at ACR Convergence 2026 and a November 9 investor webcast.
What is the ARTV price target?
The average analyst price target for ARTV is $40.00, ranging from $4 to $41, based on 5 analysts. Latest: Wedbush downgrade on Oct 27, 2026.
What do analysts rate ARTV?
Analyst ratings for ARTV: 0 Buy, 7 Hold, 3 Sell — consensus Hold.
Did ARTV beat earnings?
ARTV last reported on Aug 6, 2026: EPS -$0.63 vs -$0.63 expected — a miss of 0.8%.
Does ARTV pay a dividend?
ARTV does not currently pay a dividend.
What are ARTV support and resistance levels?
Support: $4.00, $3.62, $2.96. Resistance: $4.45, $5.08, $5.76.
What are insiders doing with ARTV?
Insider activity: SELLING, 3 buys and 12 sells in the last 90 days.
What is the latest news on ARTV?
Nov 10, 2026: Law firm opens investigation into Artiva Biotherapeutics · Nov 9, 2026: Artiva Biotherapeutics flags $10M-$15M AlloNK wind-down charges, $17M-$20M severance bill